CN Stock MarketDetailed Quotes

603235 JiangXi Tianxin Pharmaceutical

Watchlist
  • 25.86
  • +0.29+1.13%
Market Closed Nov 15 15:00 CST
11.32BMarket Cap20.31P/E (TTM)

JiangXi Tianxin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
8.49%1.61B
-4.81%1.07B
-14.46%494.5M
-18.34%1.88B
-15.02%1.49B
-9.73%1.12B
-4.61%578.12M
-8.63%2.3B
-0.48%1.75B
-2.05%1.24B
Operating revenue
8.49%1.61B
-4.81%1.07B
-14.46%494.5M
-18.34%1.88B
-15.02%1.49B
-9.73%1.12B
-4.61%578.12M
-8.63%2.3B
-0.48%1.75B
-2.05%1.24B
Other operating revenue
----
-20.90%14.41M
----
-40.82%30.6M
----
-33.57%18.22M
----
-7.61%51.71M
----
95.18%27.43M
Total operating cost
1.35%1.06B
-9.95%671.17M
-27.47%329.54M
-17.19%1.36B
-9.82%1.04B
-7.65%745.33M
9.86%454.33M
-2.79%1.64B
-0.37%1.16B
-0.11%807.08M
Operating cost
-1.08%931.58M
-12.49%618M
-25.16%296.34M
-19.71%1.16B
-10.78%941.71M
-2.58%706.2M
11.93%395.95M
1.07%1.45B
7.12%1.06B
5.30%724.9M
Operating tax surcharges
4.35%15.94M
3.48%10.07M
25.85%5.14M
-9.84%19.81M
-3.37%15.28M
-5.49%9.73M
28.86%4.09M
-3.53%21.97M
-6.32%15.81M
-15.95%10.29M
Operating expense
8.33%24.63M
7.59%17.04M
-44.25%3.09M
7.05%32.86M
5.58%22.74M
15.56%15.84M
12.46%5.54M
10.03%30.7M
-2.33%21.53M
2.36%13.71M
Administration expense
-4.79%98.97M
-8.27%58.41M
-14.01%27.93M
-5.43%136.35M
1.25%103.94M
-0.78%63.68M
3.64%32.48M
28.40%144.18M
31.81%102.66M
25.29%64.18M
Financial expense
16.24%-85.74M
12.58%-77.41M
-12,866.80%-25.73M
-13.09%-102.43M
-3.88%-102.37M
-105.44%-88.55M
-95.80%201.56K
-349.82%-90.57M
-647.90%-98.54M
-335.52%-43.1M
-Interest expense (Financial expense)
----
299.85%2.06M
----
-69.69%2.1M
----
-90.30%515.38K
----
-45.32%6.93M
----
-15.67%5.31M
-Interest Income (Financial expense)
----
-33.63%-44.31M
-99.07%-24.23M
-358.17%-74.46M
----
-4,465.15%-33.15M
-4,403.46%-12.17M
-274.53%-16.25M
----
79.53%-726.25K
Research and development
16.03%72.72M
17.25%45.05M
41.75%22.77M
25.15%111.96M
3.25%62.67M
3.58%38.42M
3.26%16.07M
51.79%89.46M
45.11%60.7M
52.20%37.09M
Credit Impairment Loss
-129.49%-1.89M
-227.63%-2.64M
-344.43%-2.36M
-2.30%3.16M
140.26%6.42M
223.15%2.07M
56.22%-530.47K
145.98%3.23M
-28.59%2.67M
59.86%-1.68M
Asset Impairment Loss
-472.13%-5.23M
-472.13%-5.23M
----
-197.36%-12.36M
5.47%-914.33K
5.47%-914.33K
----
-644.32%-4.16M
79.89%-967.27K
-110.08%-967.27K
Other net revenue
-32.17%32.26M
2.25%16.45M
64.24%11.41M
-36.20%40.49M
-18.46%47.55M
-62.35%16.09M
-61.94%6.95M
44.36%63.47M
11.19%58.32M
20.69%42.74M
Fair value change income
----
----
----
----
----
----
----
200.00%4.33M
--4.33M
--4.33M
Invest income
144.45%3.65M
-69.06%364.87K
6.51%364.87K
-68.72%2.07M
-46.47%1.49M
137.68%1.18M
-89.26%342.57K
391.22%6.63M
-11.65%2.79M
-83.53%496.16K
-Including: Investment income associates
----
----
----
-299.01%-379.69K
----
----
---269.56K
---95.16K
----
----
Asset deal income
--962.33
----
----
----
----
----
----
----
----
----
Other revenue
-11.88%35.73M
74.21%23.96M
87.85%13.4M
-10.87%47.62M
-18.07%40.55M
-66.09%13.75M
-57.07%7.14M
-8.14%53.43M
-1.72%49.5M
9.48%40.56M
Operating profit
19.72%587.74M
5.26%411.9M
34.91%176.37M
-22.53%562.22M
-24.59%490.92M
-17.96%391.31M
-37.98%130.73M
-17.23%725.7M
0.26%651M
-3.60%476.97M
Add:Non operating Income
303.64%41.46K
4,280.65%31.99K
--14.02K
89.98%6.05M
-89.49%10.27K
-90.45%730.16
----
160.11%3.18M
873.64%97.76K
1.21%7.65K
Less:Non operating expense
62.25%2.8M
296.38%1.87M
705.13%644.1K
-0.82%3.09M
-36.01%1.72M
-74.34%470.78K
-89.09%80K
-32.57%3.12M
71.49%2.69M
206.93%1.83M
Total profit
19.58%584.98M
4.92%410.06M
34.51%175.74M
-22.13%565.17M
-24.55%489.21M
-17.74%390.84M
-37.80%130.65M
-16.90%725.76M
0.10%648.4M
-3.85%475.14M
Less:Income tax cost
18.60%90.5M
6.59%64.9M
27.82%28.19M
-13.82%89.32M
-21.51%76.31M
-17.60%60.88M
-30.90%22.05M
-19.96%103.64M
-3.88%97.22M
-0.76%73.89M
Net profit
19.76%494.48M
4.61%345.17M
35.87%147.55M
-23.51%475.85M
-25.09%412.9M
-17.77%329.96M
-39.04%108.6M
-16.37%622.12M
0.84%551.18M
-4.40%401.25M
Net profit from continuing operation
19.76%494.48M
4.61%345.17M
35.87%147.55M
-23.51%475.85M
-25.09%412.9M
-17.77%329.96M
-39.04%108.6M
-16.37%622.12M
0.84%551.18M
-4.40%401.25M
Net profit of parent company owners
19.76%494.48M
4.61%345.17M
35.87%147.55M
-23.51%475.85M
-25.09%412.9M
-17.77%329.96M
-39.04%108.6M
-16.37%622.12M
0.84%551.18M
-4.40%401.25M
Earning per share
Basic earning per share
20.21%1.13
5.33%0.79
36.00%0.34
-27.81%1.09
-31.39%0.94
-26.47%0.75
-44.44%0.25
-20.11%1.51
-1.44%1.37
-4.67%1.02
Diluted earning per share
20.21%1.13
5.33%0.79
36.00%0.34
-27.81%1.09
-31.39%0.94
-26.47%0.75
-44.44%0.25
-20.11%1.51
-1.44%1.37
-4.67%1.02
Other composite income
Total composite income
19.76%494.48M
4.61%345.17M
35.87%147.55M
-23.51%475.85M
-25.09%412.9M
-17.77%329.96M
-39.04%108.6M
-16.37%622.12M
0.84%551.18M
-4.40%401.25M
Total composite income of parent company owners
19.76%494.48M
4.61%345.17M
35.87%147.55M
-23.51%475.85M
-25.09%412.9M
-17.77%329.96M
-39.04%108.6M
-16.37%622.12M
0.84%551.18M
-4.40%401.25M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Zhonghui Certified Public Accountants (Special General Partnership)
--
--
--
Zhonghui Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 8.49%1.61B-4.81%1.07B-14.46%494.5M-18.34%1.88B-15.02%1.49B-9.73%1.12B-4.61%578.12M-8.63%2.3B-0.48%1.75B-2.05%1.24B
Operating revenue 8.49%1.61B-4.81%1.07B-14.46%494.5M-18.34%1.88B-15.02%1.49B-9.73%1.12B-4.61%578.12M-8.63%2.3B-0.48%1.75B-2.05%1.24B
Other operating revenue -----20.90%14.41M-----40.82%30.6M-----33.57%18.22M-----7.61%51.71M----95.18%27.43M
Total operating cost 1.35%1.06B-9.95%671.17M-27.47%329.54M-17.19%1.36B-9.82%1.04B-7.65%745.33M9.86%454.33M-2.79%1.64B-0.37%1.16B-0.11%807.08M
Operating cost -1.08%931.58M-12.49%618M-25.16%296.34M-19.71%1.16B-10.78%941.71M-2.58%706.2M11.93%395.95M1.07%1.45B7.12%1.06B5.30%724.9M
Operating tax surcharges 4.35%15.94M3.48%10.07M25.85%5.14M-9.84%19.81M-3.37%15.28M-5.49%9.73M28.86%4.09M-3.53%21.97M-6.32%15.81M-15.95%10.29M
Operating expense 8.33%24.63M7.59%17.04M-44.25%3.09M7.05%32.86M5.58%22.74M15.56%15.84M12.46%5.54M10.03%30.7M-2.33%21.53M2.36%13.71M
Administration expense -4.79%98.97M-8.27%58.41M-14.01%27.93M-5.43%136.35M1.25%103.94M-0.78%63.68M3.64%32.48M28.40%144.18M31.81%102.66M25.29%64.18M
Financial expense 16.24%-85.74M12.58%-77.41M-12,866.80%-25.73M-13.09%-102.43M-3.88%-102.37M-105.44%-88.55M-95.80%201.56K-349.82%-90.57M-647.90%-98.54M-335.52%-43.1M
-Interest expense (Financial expense) ----299.85%2.06M-----69.69%2.1M-----90.30%515.38K-----45.32%6.93M-----15.67%5.31M
-Interest Income (Financial expense) -----33.63%-44.31M-99.07%-24.23M-358.17%-74.46M-----4,465.15%-33.15M-4,403.46%-12.17M-274.53%-16.25M----79.53%-726.25K
Research and development 16.03%72.72M17.25%45.05M41.75%22.77M25.15%111.96M3.25%62.67M3.58%38.42M3.26%16.07M51.79%89.46M45.11%60.7M52.20%37.09M
Credit Impairment Loss -129.49%-1.89M-227.63%-2.64M-344.43%-2.36M-2.30%3.16M140.26%6.42M223.15%2.07M56.22%-530.47K145.98%3.23M-28.59%2.67M59.86%-1.68M
Asset Impairment Loss -472.13%-5.23M-472.13%-5.23M-----197.36%-12.36M5.47%-914.33K5.47%-914.33K-----644.32%-4.16M79.89%-967.27K-110.08%-967.27K
Other net revenue -32.17%32.26M2.25%16.45M64.24%11.41M-36.20%40.49M-18.46%47.55M-62.35%16.09M-61.94%6.95M44.36%63.47M11.19%58.32M20.69%42.74M
Fair value change income ----------------------------200.00%4.33M--4.33M--4.33M
Invest income 144.45%3.65M-69.06%364.87K6.51%364.87K-68.72%2.07M-46.47%1.49M137.68%1.18M-89.26%342.57K391.22%6.63M-11.65%2.79M-83.53%496.16K
-Including: Investment income associates -------------299.01%-379.69K-----------269.56K---95.16K--------
Asset deal income --962.33------------------------------------
Other revenue -11.88%35.73M74.21%23.96M87.85%13.4M-10.87%47.62M-18.07%40.55M-66.09%13.75M-57.07%7.14M-8.14%53.43M-1.72%49.5M9.48%40.56M
Operating profit 19.72%587.74M5.26%411.9M34.91%176.37M-22.53%562.22M-24.59%490.92M-17.96%391.31M-37.98%130.73M-17.23%725.7M0.26%651M-3.60%476.97M
Add:Non operating Income 303.64%41.46K4,280.65%31.99K--14.02K89.98%6.05M-89.49%10.27K-90.45%730.16----160.11%3.18M873.64%97.76K1.21%7.65K
Less:Non operating expense 62.25%2.8M296.38%1.87M705.13%644.1K-0.82%3.09M-36.01%1.72M-74.34%470.78K-89.09%80K-32.57%3.12M71.49%2.69M206.93%1.83M
Total profit 19.58%584.98M4.92%410.06M34.51%175.74M-22.13%565.17M-24.55%489.21M-17.74%390.84M-37.80%130.65M-16.90%725.76M0.10%648.4M-3.85%475.14M
Less:Income tax cost 18.60%90.5M6.59%64.9M27.82%28.19M-13.82%89.32M-21.51%76.31M-17.60%60.88M-30.90%22.05M-19.96%103.64M-3.88%97.22M-0.76%73.89M
Net profit 19.76%494.48M4.61%345.17M35.87%147.55M-23.51%475.85M-25.09%412.9M-17.77%329.96M-39.04%108.6M-16.37%622.12M0.84%551.18M-4.40%401.25M
Net profit from continuing operation 19.76%494.48M4.61%345.17M35.87%147.55M-23.51%475.85M-25.09%412.9M-17.77%329.96M-39.04%108.6M-16.37%622.12M0.84%551.18M-4.40%401.25M
Net profit of parent company owners 19.76%494.48M4.61%345.17M35.87%147.55M-23.51%475.85M-25.09%412.9M-17.77%329.96M-39.04%108.6M-16.37%622.12M0.84%551.18M-4.40%401.25M
Earning per share
Basic earning per share 20.21%1.135.33%0.7936.00%0.34-27.81%1.09-31.39%0.94-26.47%0.75-44.44%0.25-20.11%1.51-1.44%1.37-4.67%1.02
Diluted earning per share 20.21%1.135.33%0.7936.00%0.34-27.81%1.09-31.39%0.94-26.47%0.75-44.44%0.25-20.11%1.51-1.44%1.37-4.67%1.02
Other composite income
Total composite income 19.76%494.48M4.61%345.17M35.87%147.55M-23.51%475.85M-25.09%412.9M-17.77%329.96M-39.04%108.6M-16.37%622.12M0.84%551.18M-4.40%401.25M
Total composite income of parent company owners 19.76%494.48M4.61%345.17M35.87%147.55M-23.51%475.85M-25.09%412.9M-17.77%329.96M-39.04%108.6M-16.37%622.12M0.84%551.18M-4.40%401.25M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Zhonghui Certified Public Accountants (Special General Partnership)------Zhonghui Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data